Skip to main content

Vistagen Therapeutics, Inc.

VTGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001411685

No open-market purchases or sales by Vistagen Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $2.54M in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Vistagen Therapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
51
+3 vs. Q1 2025
Shares held
15.5M
−449.8K (−2.8%) vs. Q1 2025
Total value
$30.3M
−$8.75M (−22.4%) vs. Q1 2025
New holders
6
17 more added
Sold out
3
12 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VTGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 51 institutions
Q1 2021: 74 institutionsQ2 2021: 101 institutionsQ3 2021: 105 institutionsQ4 2021: 106 institutionsQ1 2022: 116 institutionsQ2 2022: 112 institutionsQ3 2022: 93 institutionsQ4 2022: 86 institutionsQ1 2023: 83 institutionsQ2 2023: 33 institutionsQ3 2023: 34 institutionsQ4 2023: 46 institutionsQ1 2024: 42 institutionsQ2 2024: 43 institutionsQ3 2024: 47 institutionsQ4 2024: 54 institutionsQ1 2025: 48 institutionsQ2 2025: 51 institutionsQ3 2025: 58 institutionsQ4 2025: 55 institutionsQ1 2026: 56 institutionsQ2 2026: 48 institutions
Value heldQ2 2025: $30.3M
Q1 2021: $225.2MQ2 2021: $389.0MQ3 2021: $360.2MQ4 2021: $269.2MQ1 2022: $167.8MQ2 2022: $122.1MQ3 2022: $9.13MQ4 2022: $4.15MQ1 2023: $4.79MQ2 2023: $1.82MQ3 2023: $15.7MQ4 2023: $90.0MQ1 2024: $90.8MQ2 2024: $56.3MQ3 2024: $45.3MQ4 2024: $44.9MQ1 2025: $39.0MQ2 2025: $30.3MQ3 2025: $81.8MQ4 2025: $8.84MQ1 2026: $8.12MQ2 2026: $2.54M
Institutions holding VTGN and their total value by quarter
QuarterHoldersValue
Q2 202648$2.54M
Q1 202656$8.12M
Q4 202555$8.84M
Q3 202558$81.8M
Q2 202551$30.3M
Q1 202548$39.0M
Q4 202454$44.9M
Q3 202447$45.3M
Q2 202443$56.3M
Q1 202442$90.8M
Q4 202346$90.0M
Q3 202334$15.7M
Q2 202333$1.82M
Q1 202383$4.79M
Q4 202286$4.15M
Q3 202293$9.13M
Q2 2022112$122.1M
Q1 2022116$167.8M
Q4 2021106$269.2M
Q3 2021105$360.2M
Q2 2021101$389.0M
Q1 202174$225.2M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Vistagen Therapeutics, Inc.; share changes are against Q1 2025.

Institutions holding VTGN in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
TCG Crossover Management, LLC2,676,580$5.35M0.61%00.0%Unchanged
StemPoint Capital LP2,413,254$4.12M1.33%+46,700+2.0%Added
Nantahala Capital Management, LLC1,978,492$3.96M0.28%00.0%Unchanged
Vanguard Group Inc1,759,642$3.52M0.00%−200,530−10.2%Reduced
Commodore Capital LP1,575,000$3.15M0.22%00.0%Unchanged
JPMorgan Chase & Co748,862$1.50M0.00%−2,014−0.3%Reduced
Ikarian Capital, LLC601,703$1.20M0.40%00.0%Unchanged
Sphera Funds Management Ltd.447,939$895.9K0.23%−342,611−43.3%Reduced
ADAR1 Capital Management, LLC420,765$841.5K0.14%00.0%Unchanged
BlackRock, Inc.416,889$833.8K0.00%+551+0.1%Added
Diadema Partners LP403,922$807.8K0.50%−162,053−28.6%Reduced
Geode Capital Management, LLC272,907$546.0K0.00%+2,720+1.0%Added
Almitas Capital LLC261,399$522.8K0.13%+6,744+2.6%Added
AdvisorShares Investments LLC203,114$406.2K0.07%+44,000+27.7%Added
Boothbay Fund Management, LLC177,858$355.7K0.01%00.0%Unchanged
BML Capital Management, LLC150,000$300.0K0.23%00.0%Unchanged
Susquehanna International Group, LLP115,368$230.7K0.00%+50,587+78.1%Added
State Street Corp96,858$193.7K0.00%00.0%Unchanged
Jane Street Group, LLC95,051$190.1K0.00%+95,051New
Two Sigma Investments, LP89,451$178.9K0.00%−23,056−20.5%Reduced
Persistent Asset Partners Ltd86,819$173.6K0.15%−34,832−28.6%Reduced
Blair William & Co85,866$171.7K0.00%−15,000−14.9%Reduced
Northern Trust Corp48,093$96.2K0.00%00.0%Unchanged
Dimensional Fund Advisors LP43,362$86.7K0.00%+25,817+147.1%Added
Renaissance Technologies LLC40,500$81.0K0.00%+15,700+63.3%Added
Marshall Wace, LLP34,638$69.3K0.00%+34,638New
American Century Companies Inc31,063$62.1K0.00%00.0%Unchanged
Two Sigma Advisers, LP25,832$51.7K0.00%+15,100+140.7%Added
Charles Schwab Investment Management Inc23,302$46.6K0.00%00.0%Unchanged
Virtu Financial LLC22,946$46.0K0.00%+22,946New
UBS Group AG22,813$45.6K0.00%−2,966−11.5%Reduced
Simplex Trading, LLC22,536$45.0K0.00%+20,134+838.2%Added
HighTower Advisors, LLC20,828$41.7K0.00%00.0%Unchanged
Kestra Advisory Services, LLC20,033$40.1K0.00%00.0%Unchanged
Morgan Stanley12,147$24.3K0.00%−39,138−76.3%Reduced
Tower Research Capital LLC (TRC)7,721$15.4K0.00%+7,721New
Truvestments Capital LLC7,155$14.3K0.00%+7,155New
Group One Trading, L.P.7,142$14.3K0.00%+1,573+28.2%Added
Raymond James Financial Inc6,410$12.8K0.00%+6,410New
Advisor Group Holdings, Inc.4,493$8.99K0.00%−1,001−18.2%Reduced
Citigroup Inc3,539$7.08K0.00%+3,536+117,866.7%Added
Royal Bank of Canada3,297$7.00K0.00%+2,386+261.9%Added
Bank of America Corp3,378$6.76K0.00%+2,701+399.0%Added
Performa Ltd (US), LLC1,000$2.00K0.00%00.0%Unchanged
MAI Capital Management526$1.05K0.00%−50−8.7%Reduced
CWM, LLC582$1.00K0.00%−1,000−63.2%Reduced
BNP Paribas Arbitrage, SA478$9560.00%+7+1.5%Added
SBI Securities Co., Ltd.288$5760.00%+2+0.7%Added
Jones Financial Companies LLLP114$2250.00%+34+42.5%Added
Fairman Group, LLC29$580.00%00.0%Unchanged
Barclays PLC1$20.00%00.0%Unchanged
Prosperity Wealth Management, Inc.0$00.00%−27,600−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−10,088−100.0%Sold out
SJS Investment Consulting Inc.0$00.00%−100−100.0%Sold out